A predicted dimer-based polymorph of 10,11-dihydrocarbamazepine (Form IV)

被引：21

作者：

Arlin, Jean-Baptiste ^{[1
]}

Johnston, Andrea ^{[1
]}

Miller, Gary J. ^{[1
]}

Kennedy, Alan R. ^{[2
]}

Price, Sarah L. ^{[3
]}

Florence, Alastair J. ^{[1
]}

机构：

[1] Univ Strathclyde, Solid State Res Grp, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland

[2] Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Glasgow G1 1XL, Lanark, Scotland

[3] UCL, Dept Chem, London WC1H 0AJ, England

来源：

CRYSTENGCOMM | 2010年 / 12卷 / 01期

基金：

英国工程与自然科学研究理事会;

关键词：

CRYSTAL-STRUCTURES; PARALLEL CRYSTALLIZATION; PACKING MOTIFS; CARBAMAZEPINE; SIMILARITY; PATTERNS;

D O I：

10.1039/b914365c

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

A novel polymorph of 10,11-dihydrocarbamazepine (form IV), which had been predicted to be thermodynamically feasible, was obtained from the vapour phase and displays an R-2(2)(8) hydrogen bonded dimer motif in contrast to the catemeric motifs in forms I-III.

引用

页码：64 / 66

页数：3

共 24 条

[1] X-RAY CRYSTALLOGRAPHIC CHARACTERIZATION OF 10,11-DIHYDRO-5H-DIBENZ[B,F]AZEPINE-5-CARBOXAMIDE [J].

BANDOLI, G ;

NICOLINI, M ;

ONGARO, A ;

VOLPE, G ;

RUBELLO, A .

JOURNAL OF CRYSTALLOGRAPHIC AND SPECTROSCOPIC RESEARCH, 1992, 22 (02) :177-183

[2] Importance of molecular shape for the overall stability of hydrogen bond motifs in the crystal structures of various carbamazepine-type drug molecules [J].

Cruz Cabeza, Aurora J. ;

Day, Graeme M. ;

Motherwell, W. D. Samuel ;

Jones, William .

CRYSTAL GROWTH & DESIGN, 2007, 7 (01) :100-107

[3] Amide pyramidalization in carbamazepine: A flexibility problem in crystal structure prediction? [J].

Cruz Cabeza, Aurora J. ;

Day, Graeme M. ;

Motherwell, W. D. Samuel ;

Jones, William .

CRYSTAL GROWTH & DESIGN, 2006, 6 (08) :1858-1866

[4]

CYR TD, 1987, J ASSOC OFF ANA CHEM, V70, P836

[5] ENCODING AND DECODING HYDROGEN-BOND PATTERNS OF ORGANIC-COMPOUNDS [J].

ETTER, MC .

ACCOUNTS OF CHEMICAL RESEARCH, 1990, 23 (04) :120-126

[6] Two-dimensional similarity between forms I and II of cytenamide, a carbamazepine analogue [J].

Florence, A. J. ;

Bedford, C. T. ;

Fabbiani, F. P. A. ;

Shankland, K. ;

Gelbrich, T. ;

Hursthouse, M. B. ;

Shankland, N. ;

Johnston, A. ;

Fernandes, P. .

CRYSTENGCOMM, 2008, 10 (07) :811-813

[7] A catemer-to-dimer structural transformation in cyheptamide [J].

Florence, A. J. ;

Shankland, K. ;

Gelbrich, T. ;

Hursthouse, M. B. ;

Shankland, N. ;

Johnston, A. ;

Fernandes, P. ;

Leech, C. K. .

CRYSTENGCOMM, 2008, 10 (01) :26-28

[8] Control and prediction of packing motifs: a rare occurrence of carbamazepine in a catemeric configuration [J].

Florence, A. J. ;

Leech, C. K. ;

Shankland, N. ;

Shankland, K. ;

Johnston, A. .

CRYSTENGCOMM, 2006, 8 (10) :746-747

[9] Indexing powder patterns in physical form screening: Instrumentation and data quality [J].

Florence, AJ ;

Baumgartner, B ;

Weston, C ;

Shankland, N ;

Kennedy, AR ;

Shankland, K ;

David, WIF .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (09) :1930-1938

[10] An automated platform for parallel crystallization of small organic molecules [J].

Florence, Alastair J. ;

Johnston, Andrea ;

Fernandes, Philippe ;

Shankland, Norman ;

Shankland, Kenneth .

JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2006, 39 :922-924

← 1 2 3 →